luzindole has been researched along with ferric ammonium citrate in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (ferric ammonium citrate) | Trials (ferric ammonium citrate) | Recent Studies (post-2010) (ferric ammonium citrate) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 259 | 6 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Z; Bikkuzin, T; Cai, B; Cao, Y; Ding, F; Dong, C; Feng, C; Gong, R; Han, Z; Huang, Q; Idiiatullina, E; Li, Y; Liu, T; Pavlov, V; Wang, D; Wang, N; Yan, G; Yang, F; Yang, L; Yuan, Y; Zhang, L | 1 |
1 other study(ies) available for luzindole and ferric ammonium citrate
| Article | Year |
|---|---|
Melatonin protects bone marrow mesenchymal stem cells against iron overload-induced aberrant differentiation and senescence.
Topics: Adipogenesis; Animals; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cellular Senescence; Ferric Compounds; Iron Overload; Iron-Dextran Complex; Male; MAP Kinase Signaling System; Melatonin; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mitochondria; Osteogenesis; Quaternary Ammonium Compounds; Reactive Oxygen Species; Tryptamines | 2017 |